ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,764 | -31.2% | 3,443 | -15.3% | 0.00% | – |
Q2 2023 | $27,276 | +18.7% | 4,065 | +56.2% | 0.00% | – |
Q1 2023 | $22,984 | +48.3% | 2,603 | +28.4% | 0.00% | – |
Q4 2022 | $15,494 | +54.9% | 2,028 | +44.5% | 0.00% | – |
Q3 2022 | $10,000 | +11.1% | 1,403 | +30.9% | 0.00% | – |
Q2 2022 | $9,000 | +200.0% | 1,072 | +337.6% | 0.00% | – |
Q1 2022 | $3,000 | +50.0% | 245 | +469.8% | 0.00% | – |
Q1 2021 | $2,000 | – | 43 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |